AI Article Synopsis
- Most hepatocellular carcinoma cases are often detected late, leading to high death rates, so early diagnosis is crucial for better patient outcomes.
- In recent years, researchers in Asia have developed risk score models specifically for people with chronic hepatitis B to identify those at high risk and enhance early detection.
- The paper discusses risk factors, evaluates these predictive models, and also reviews how antiviral treatments can impact the likelihood of developing hepatocellular carcinoma.
Article Abstract
Most hepatocellular carcinoma are diagnosed at an advanced stage and thereby have a high mortality rate. Thus, the key to improving patient prognosis is early diagnosis of hepatocellular carcinoma. In recent years, Asian scholars have summarized a series of hepatocellular carcinoma risk score model for population with chronic hepatitis B, which can help to identify high-risk groups early and improve the early diagnosis rate. This paper briefly analyzes the risk factors and validated risk model for early prediction of hepatitis B virus-related hepatocellular carcinoma, and further reviews the effect of antiviral therapy on the risk of hepatocellular carcinoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3760/cma.j.cn501113-20190201-00042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!